In animal models, combined treatment of HZ-A-018 and 5-FU also suppressed the expression of RRM2, as determined by Western blotting of tumor tissues (Figure 4E) and in situ immunohistochemistry of tumor sections (Figure 4F). Here, RRM2 is linked to neoplasm.